Citation Impact
Citing Papers
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
2009 Nature
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome
2008
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
2014
Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI)
2014
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
2018 StandoutNobel
Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
2005
Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation
2016 Standout
Cognitive decline in older adults with a history of traumatic brain injury
2012
AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer
2018
The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies
2012
NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
2013
The World report on ageing and health: a policy framework for healthy ageing
2015 Standout
The role and regulation of Maf proteins in cancer
2023
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Mild traumatic brain injury does not predict acute postconcussion syndrome
2007
Delirium in elderly people
2013 Standout
Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species
2013 Standout
A Phase 3, Randomized, Double-Blind Comparative Study of the Efficacy and Safety of Topical Recombinant Human Thrombin and Bovine Thrombin in Surgical Hemostasis
2007
Cancer drug resistance: an evolving paradigm
2013 Standout
Cognitive impairment and pain management: Review of issues and challenges
2007
Macrophages in immunoregulation and therapeutics
2023 Standout
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples
2009
Hepatocellular carcinoma
2021 Standout
Neuropsychiatric Problems After Traumatic Brain Injury: Unraveling the Silent Epidemic
2009
IRF4 addiction in multiple myeloma
2008 Nature
Geriatric Syndromes: Clinical, Research, and Policy Implications of a Core Geriatric Concept
2007 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
PrognoScan: a new database for meta-analysis of the prognostic value of genes
2009
Head injury and dementia
2004
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Fast, Systematic, and Continuous Delirium Assessment in Hospitalized Patients: The Nursing Delirium Screening Scale
2005
Inhibiting eukaryotic transcription. Which compound to choose? How to evaluate its activity?
2011 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Multimodal biomedical AI
2022 Standout
Genetic events in the pathogenesis of multiple myeloma
2007
Systemic amyloidosis
2015 Standout
The Glymphatic System: A Beginner’s Guide
2015 Standout
Alzheimer's disease
2006 Standout
Sickle-cell disease
2010 Standout
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
2014 Standout
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors
2009
Mild Traumatic Brain Injury in U.S. Soldiers Returning from Iraq
2008 Standout
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
2007
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
RNAi modulation of placental sFLT1 for the treatment of preeclampsia
2018
Applications of machine learning in drug discovery and development
2019 Standout
The role of telomeres and telomerase in cirrhosis and liver cancer
2019
Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive
2007
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
The molecular characterization and clinical management of multiple myeloma in the post-genome era
2009
Multicenter Comparison of the Contraceptive Ring and Patch
2008
Polycystic ovary syndrome
2016 Standout
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib
2015
BRD4 inhibitors block telomere elongation
2017 Nobel
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
2018
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Increased Rates of Mild Traumatic Brain Injury Among Older Adults in US Emergency Departments, 2009-2010
2015
Risk factors for falls among older adults: A review of the literature
2013 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Neuronal Death and Oxidative Stress in the Developing Brain
2010
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010
2011
The Fibroblast Growth Factor signaling pathway
2015 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Management of MPN beyond JAK2
2014
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Combination contraceptives: effects on weight
2014
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
2012 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Superior results of Total Therapy 3 (2003-33) in gene expression profiling–defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance
2010
Modeling Nonhomogeneous Markov Processes via Time Transformation
2007
Toll-like receptors: lessons to learn from normal and malignant human B cells
2008
Estimating the global incidence of traumatic brain injury
2018 Standout
Multi-State Models for Panel Data: ThemsmPackage forR
2011 Standout
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
2006
Multiple Myeloma
2010
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)
2011
Understanding TERT Promoter Mutations: A Common Path to Immortality
2016
Sarcopenia: European consensus on definition and diagnosis
2010 Standout
Multiple Myeloma
2011 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Therapy for myeloproliferative neoplasms: when, which agent, and how?
2014
Telomere-driven diseases and telomere-targeting therapies
2017
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib
2006
Works of Bart Burington being referenced
Tumor Cell Gene Expression Changes Following Short-term In vivo Exposure to Single Agent Chemotherapeutics are Related to Survival in Multiple Myeloma
2008
A Comparison Between the Vaginal Ring and Oral Contraceptives
2004
Psychiatric Illness Following Traumatic Brain Injury in an Adult HealthMaintenance Organization Population
2004
Flexible Implementations of Group Sequential Stopping Rules Using Constrained Boundaries
2003
Clinical presentation of delirium in patients undergoing hematopoietic stem cell transplantation
2005
A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer
2014
Delirium in patients undergoing hematopoietic stem cell transplantation
2002
Psychiatric illness after mild traumatic brain injury in children11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the author(s) or on any organization with which the author(s) is/are associated.
2004
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia
2015
Imetelstat Rapidly Induces and Maintains Substantial Hematologic and Molecular Responses in Patients with Essential Thrombocythemia (ET) Who Are Refractory or Intolerant to Prior Therapy: Preliminary Phase II Results
2012
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
2006
The molecular classification of multiple myeloma
2006